Od 260/280

The two wavelengths provide a comparative signal rather than an isolated purity score. At 260 nm, nucleic-acid bases contribute strongly to absorbance, while absorbance at 280 nm reflects aromatic amino acids in proteins. A shift in the balance between these readings can therefore reveal that material other than the intended nucleic acid is influencing the sample measurement.

An altered ratio suggests that the sample composition differs from a preparation dominated by nucleic acid signal. Protein carryover is one possible explanation because proteins contribute absorbance at 280 nm, while other contaminants may also affect the measurement. The ratio indicates potential interference, but it does not by itself identify the precise contaminant or explain its source.

The ratio provides information about the balance between nucleic-acid and protein-associated absorbance, whereas concentration describes how much nucleic acid is present. Considering both measurements helps distinguish a sample with sufficient material from one whose purity may compromise downstream work. Additional quality tests provide complementary evidence, supporting more confident decisions about sample suitability.

Interpretation focuses on whether the absorbance relationship is consistent with a preparation suitable for its intended molecular biology use. A ratio affected by protein or other carryover raises concern that the extract may not perform reliably, even when nucleic acid is detectable. This makes the measurement a screening step for evaluating extract quality before further experiments.

The measurement compares a sample’s ultraviolet absorbance at 260 nm with its absorbance at 280 nm, producing the A260/A280 ratio. Researchers then consider that value together with the measured nucleic acid concentration and other quality information. This workflow turns two wavelength-specific signals into a practical assessment of extract quality rather than relying on absorbance at one wavelength alone.

Researchers commonly evaluate extracts after nucleic acid preparation and before polymerase chain reaction, sequencing, cloning, or related procedures. Checking the sample at this stage can reveal protein or other contaminant carryover before it affects later work. The result helps determine whether the extract warrants further quality assessment before being used in the planned experiment.